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Mutations in the PLA2G6 gene have been identified in autosomal neurodegenerative 
diseases, such as dystonia-parkinsonism and infantile neuronal dystrophy (INAD). Those 
with dystonia-parkinsonism develop a parkinsonian movement disorder between the 
ages of 15 and 30. The PLA2G6 gene encodes an enzyme known as calcium-independent 
phospholipase A2 beta (iPLA2β), which hydrolyzes the sn-2 acyl groups of phospholipids 
and lysophospholipids, producing free fatty acids. In previous studies we found that 
PLA2G6 mutations associated with INAD cause loss of function for the enzyme, but 
PLA2G6 mutations associated with a dystonia-parkinsonism phenotype do not impair 
the catalytic function in A2 phospholipase and lysophospholipase assays. Due to the 
recessive nature of dystonia-parkinsonism, we hypothesize that mutations in PLA2G6 
cause loss of PLA2G6 function. In this study, we investigated the A1 phospholipase 
activity of PLA2G6 and whether dystonia-parkinsonism mutations impair this aspect 
of PLA2G6 function.
We produced wild-type (WT) PLA2G6 and mutant PLA2G6 proteins in HEK293 
cells by transient transfection of expression plasmids. The A1 phospholipase activity 
(hydrolysis of the sn-1 acyl group) was measured in sonicated cell extracts using the 
fluorogenic phospholipase substrate, PEDA1, at 37°C. We find that after controlling for 
enzyme concentration, catalytic activity of mutant PLA2G6 proteins is not significantly 
different from WT. Some mutations even have slightly greater catalytic activity for 
PEDA1 when compared to WT.
These results were compared to previous studies involving mutations in PLA2G6 and 
their association with diseases such as INAD and dystonia-parkinsonism. The findings 
solidified the notion that dystonia-parkinsonism mutations do not directly impair 
PLA2G6 catalytic activity in a significant manner, and therefore may impair PLA2G6 
function by other mechanisms.
